ANI Pharmaceuticals Launches Generic Monoket Following FDA Approval; Shares Rise In Pre-Market
ANI PharmaceuticalsANI Pharmaceuticals(US:ANIP) RTTNews·2026-04-08 19:19

公司动态 - 公司宣布已在美国食品药品监督管理局最终批准后，推出了单硝酸异山梨酯片 [1] - 该产品是Lannett公司销售的血管扩张剂Monoket的仿制药，用于治疗心绞痛 [1] 市场反应 - 公司股价在周二收盘于79.47美元后，于盘前交易中上涨超过7% [1]

ANI Pharmaceuticals Launches Generic Monoket Following FDA Approval; Shares Rise In Pre-Market - Reportify